Nonclinical microbiological, safety, toxicology, and pharmacokinetic services
Ended Awarded Last action
- Contract number
- 75N93020F00005
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,400,498
Award facts
- Contract value 100% obligated
- $10,400,497.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$581,034 | |
| Funding Only Action | -$6,103 | |
| Exercise an Option | $2,666,685 | |
| Exercise an Option | $2,631,694 | |
| Exercise an Option | $848,712 | |
| Change Order | -$537,837 | |
| Original award | $5,378,381 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on August 25, 2020, under the Nonclinical Services for Development of Interventional Agents IDIQ, with a ceiling value of $10.4 million, to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of those funds.
The order covers nonclinical microbiological, safety, toxicology, and pharmacokinetic services, with place of performance in Menlo Park, CA. The ultimate completion date was August 24, 2022. Pricing is cost-plus-fixed-fee.
Government-invoiced labor across the reported fiscal years shows FY2021 activity of $4 million with 7.0 FTEs and 14,584 contractor hours at a derived rate of $274.76 per hour, and FY2022 activity of $6 million with 6.5 FTEs and 13,436 contractor hours at $444.24 per hour, reflecting rising labor pricing. Sri International self-performed all reported hours with no subcontractors reported.
Quick answers
Who was awarded contract 75N93020F00005?
75N93020F00005 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 25, 2020.
How much is contract 75N93020F00005 worth?
The government has obligated $10,400,498 on 75N93020F00005.
Is contract 75N93020F00005 an order under another contract?
Yes. 75N93020F00005 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93020F00005 competed?
The extent of competition for 75N93020F00005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award